entvantagedx
Austin, US · 1 known investors
Find your way into entvantagedx
ENTvantage Dx develops rapid, in-office diagnostic tests for primary care physicians and otolaryngologists to identify the causes of ear, nose, and throat illnesses. The company operates in the in-vitro diagnostics sector serving the medical diagnostics industry.
Founders & leadership
JS
Joe SkrabaCEO
Board
RH
Rick HawkinsChairman of the Board
Investors · 1
Non-dilutive funding · 2 SBIR/STTR awards
Federal grants — no equity taken| Agency | Phase | Year | Amount |
|---|---|---|---|
| National Institutes of Health (NIH)National Institutes of Health | Phase II | 2021 | $1.7M |
| National Institutes of Health (NIH)National Institutes of Health | Phase II | 2020 | $762.7K |
Source: SBIR.gov award data (U.S. Small Business Administration). SBIR/STTR awards are competitive federal R&D grants and contracts — non-dilutive capital alongside any venture rounds above.
Frequently asked questions
- What does entvantagedx do?
- ENTvantage Dx develops rapid, in-office diagnostic tests for primary care physicians and otolaryngologists to identify the causes of ear, nose, and throat illnesses. The company operates in the in-vitro diagnostics sector serving the medical diagnostics industry.
- Who are entvantagedx's investors?
- entvantagedx's investors include Central Texas Angel Network.
- Where is entvantagedx headquartered?
- entvantagedx is headquartered in Austin, US.